We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BL icon
751
BlackLine
BL
$1.82B
$1.83M 0.02%
22,017
+4,235
+24% +$283K
TKR icon
752
Timken Company
TKR
$9.1B
$1.83M 0.02%
40,120
+1,207
+3% +$47.7K
CLH icon
753
Clean Harbors
CLH
$16.9B
$1.82M 0.02%
30,365
+893
+3% +$49.8K
BATL icon
754
Battalion Oil
BATL
$29.5M
$1.82M 0.02%
191,620
WING icon
755
Wingstop
WING
$3.1B
$1.82M 0.02%
13,094
NTCT icon
756
NETSCOUT
NTCT
$2.89B
$1.82M 0.02%
71,111
+3,370
+5% +$87.1K
EXPO icon
757
Exponent
EXPO
$3.24B
$1.81M 0.02%
22,415
+829
+4% +$59.7K
FULT icon
758
Fulton Financial
FULT
$4.69B
$1.81M 0.02%
172,272
+9,844
+6% +$107K
EQT icon
759
EQT Corp
EQT
$33.8B
$1.81M 0.02%
151,760
+5,018
+3% +$65.8K
FL
760
DELISTED
Foot Locker
FL
$1.8M 0.02%
61,874
+433
+0.7% +$11.4K
NEOG icon
761
Neogen
NEOG
$2.59B
$1.8M 0.02%
46,466
+3,318
+8% +$112K
SNV
762
DELISTED
Synovus
SNV
$1.8M 0.02%
87,466
+3,348
+4% +$64.8K
ENR icon
763
Energizer
ENR
$1.55B
$1.8M 0.02%
37,807
+878
+2% +$35.9K
BYD icon
764
Boyd Gaming
BYD
$6.05B
$1.79M 0.02%
85,884
+6,290
+8% +$115K
CTRA
765
DELISTED
Coterra Energy
CTRA
$1.79M 0.02%
104,241
-906
-0.9% -$17.6K
SFM icon
766
Sprouts Farmers Market
SFM
$7.71B
$1.79M 0.02%
69,948
+2,135
+3% +$48.9K
LGND icon
767
Ligand Pharmaceuticals
LGND
$5.76B
$1.79M 0.02%
25,614
-1,544
-6% -$97.9K
IDCC icon
768
InterDigital
IDCC
$8.88B
$1.78M 0.02%
31,500
+392
+1% +$20.8K
PNFP icon
769
Pinnacle Financial Partners Inc
PNFP
$16.2B
$1.78M 0.02%
42,340
+1,028
+2% +$40.8K
RDFN
770
DELISTED
Redfin
RDFN
$1.78M 0.02%
42,391
+2,552
+6% +$67.2K
NVRO
771
DELISTED
NEVRO CORP.
NVRO
$1.77M 0.02%
14,788
+1,758
+13% +$209K
DVA icon
772
DaVita
DVA
$11.4B
$1.76M 0.02%
22,299
-816
-4% -$63.7K
EPC icon
773
Edgewell Personal Care
EPC
$1.31B
$1.76M 0.02%
56,553
+2,735
+5% +$76.6K
FLR icon
774
Fluor
FLR
$7B
$1.76M 0.02%
145,807
+65,346
+81% +$686K
JACK icon
775
Jack in the Box
JACK
$358M
$1.76M 0.02%
23,692
-1,447
-6% -$89.2K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.